SCHEMBL1966964

SCHEMBL1966964

COC(=O)c1c(O)c2cc(Cl)cn2n(Cc2cccnc2)c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
HSP90AA1 P07900 1/20 0.47
HSP90B1 P14625 1/20 0.47
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
ADRA1D P25100 1/20 0.41
GABRA5 P31644 4/20 0.40
GABRA1 P14867 3/20 0.40
FEN1 P39748 1/20 0.39
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RECQL P46063 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SRC P12931 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1966780 0.85 MAPT (0.41) KDM4EHSP90AA1HSP90B1MEN1KMT2A
SCHEMBL1969356 0.85 EGLN1 (0.49) KDM4EMEN1HTTKMT2AALDH1A1
SCHEMBL1967484 0.83 GPR132 (0.43) KDM4ETSHRADRA1DGABRA5GABRA1
SCHEMBL1967481 0.83 GPR132 (0.43) KDM4ETSHRADRA1DGABRA5GABRA1
SCHEMBL1966356 0.83 AR (0.40) MEN1KMT2AALDH1A1
SCHEMBL1969294 0.83 HSP90AA1 (0.41) KDM4EHSP90AA1HSP90B1MAPK1MEN1
SCHEMBL1964099 0.83 HSP90B1 (0.41) KDM4EHSP90B1FEN1MEN1HTT
SCHEMBL1964900 0.81 HSP90B1 (0.46) KDM4EHSP90AA1HSP90B1TSHRMAPK1
SCHEMBL1965536 0.80 KDM4E (0.45) KDM4EMEN1KMT2AALDH1A1SRC
SCHEMBL1966448 0.76 SRC (0.48) MAPK1ADRA1DGABRA5GABRA1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334682-B1 PYRROLO [ 1, 2 -B] PYRIDAZINE DERIVATIVES AND THEIR USE AS HIF MODULATORS FIBROGEN INC (US) 2017-10-04 EP disclosed
US-8217043-B2 Compounds and methods for their use FIBROGEN, INC. (US) 2012-07-10 US disclosed
EP-2334682-A1 PYRROLO [ 1, 2 -B] PYRIDAZINE DERIVATIVES AND THEIR USE AS HIF MODULATORS Fibrogen, Inc. (US) 2011-06-22 EP disclosed
WO-2010022240-A1 PYRROLO [ 1, 2 -B] PYRIDAZINE DERIVATIVES AND THEIR USE AS HIF MODULATORS FIBROGEN, INC. (US) 2010-02-25 WO disclosed
US-20100047367-A1 COMPOUNDS AND METHODS FOR THEIR USE FIBROGEN, INC. 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100047367-A1 COMPOUNDS AND METHODS FOR THEIR USE HIF1AN, HIF1A, EGLN3 KDM4E 471/4885HSP90AA1 147/4885HSP90B1 108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.